Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Januar 2024

Genmab — Januar 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • JørgenVarnæsJ Offline
    JørgenVarnæsJ Offline
    JørgenVarnæs
    wrote on sidst redigeret af
    #1061

    Am I the only one wondering about the silence from GEN?

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #1062

      agree. this is more for the hypothetical case that a potential bidder could decrease this cost price by selling off the CD38 franchise

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #1063

        it is the quiet period JV. You will hear from Jan again after the earnings.

        1 Reply Last reply
        0
        • JørgenVarnæsJ Offline
          JørgenVarnæsJ Offline
          JørgenVarnæs
          wrote on sidst redigeret af
          #1064

          …and such a transaction would unlock the value of the pipeline.

          1 Reply Last reply
          0
          • JørgenVarnæsJ Offline
            JørgenVarnæsJ Offline
            JørgenVarnæs
            wrote on sidst redigeret af
            #1065

            Such a shame it takes them 7-8 months to prepare the accounts

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #1066

              weeks?

              1 Reply Last reply
              0
              • JørgenVarnæsJ Offline
                JørgenVarnæsJ Offline
                JørgenVarnæs
                wrote on sidst redigeret af
                #1067

                They use to be very slow

                1 Reply Last reply
                0
                • J Offline
                  J Offline
                  JKY_VH
                  wrote on sidst redigeret af
                  #1068

                  after all, there are large sums to be counted;-)

                  1 Reply Last reply
                  0
                  • JørgenVarnæsJ Offline
                    JørgenVarnæsJ Offline
                    JørgenVarnæs
                    wrote on sidst redigeret af
                    #1069

                    I have always been envious at the GEN CFO. Seems they do very little but employee share programs…

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #1070

                      Don’t forget the most likely bidder is jnj. They don’t have to sell cd38 rights.

                      1 Reply Last reply
                      0
                      • JørgenVarnæsJ Offline
                        JørgenVarnæsJ Offline
                        JørgenVarnæs
                        wrote on sidst redigeret af
                        #1071

                        Back in the day I did a DCF analysis for the purchase of 2 double hull VLCCs - went to lunch, came back, had a look at the numbers and realized that the numbers corresponded 1-to-1 to the purchase of a family sized Toyota. Only difference was my numbers were in USD and for ease we removed the last three 000’s

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #1072

                          @Bulder we don't know if JNJ is interested in any other part of the business besides CD38. Maybe they would actually be happy to buy the CD38 it they could get it at the right price and let someone else run with the remainder. But it is all fiction for now.

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #1073

                            well and the other duobodies ofcourse they own

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              Pensionisten
                              wrote on sidst redigeret af
                              #1074

                              Hvor mange C25 selskaber er blevet opkøbt indenfor de seneste 10-20 år? Har ikke kunnet finde noget materiale herom. Mon ikke der er ganske, ganske få? 😉

                              1 Reply Last reply
                              0
                              • JørgenVarnæsJ Offline
                                JørgenVarnæsJ Offline
                                JørgenVarnæs
                                wrote on sidst redigeret af
                                #1075

                                GN var ved at blive købt af Sonova for små 20 år siden - men phonak i tyskland bestak en dommer og fik handlen ødelagt. Domstolen dømte handlen ulovlig i hele verden. Korrupte jurister findes ikke kun i pharma…

                                1 Reply Last reply
                                0
                                • JørgenVarnæsJ Offline
                                  JørgenVarnæsJ Offline
                                  JørgenVarnæs
                                  wrote on sidst redigeret af
                                  #1076

                                  Jeg tabte voldsomt med penge på det

                                  1 Reply Last reply
                                  0
                                  • G Offline
                                    G Offline
                                    gentogen
                                    wrote on sidst redigeret af
                                    #1077

                                    Som lille pip er 50/50 med Abbvie jsådan set ikke ikke en ren 50/50. Abbvie betalte cirka 5 millarder kr. for aftalen forud plus der i den oprindelige aftale i alt er milestones for over 20 milliarder i kr. (aftalen er justeret siden, men mange af disse milliarder vedrører givetvis epco). Så Genmabs faktiske omkostning på udvikling er langt fra 50%

                                    1 Reply Last reply
                                    0
                                    • JørgenVarnæsJ Offline
                                      JørgenVarnæsJ Offline
                                      JørgenVarnæs
                                      wrote on sidst redigeret af
                                      #1078

                                      Det ændrer ikke på ræsonnementet - GEN har stadig cash to burn, men sælger sin egen KYSO til spotpris

                                      1 Reply Last reply
                                      0
                                      • JørgenVarnæsJ Offline
                                        JørgenVarnæsJ Offline
                                        JørgenVarnæs
                                        wrote on sidst redigeret af
                                        #1079

                                        Cannot make the ends meet!

                                        1 Reply Last reply
                                        0
                                        • JørgenVarnæsJ Offline
                                          JørgenVarnæsJ Offline
                                          JørgenVarnæs
                                          wrote on sidst redigeret af
                                          #1080

                                          I det øjeblik, der ikke er tale om præklinisk udvikling er Genmab ikke med længere. Men det er der pengene bliver skabt

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper